secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2024-01-05T23:59:59+00:00
Accession:  0001493152-24-001398
Event type: debt
Sentiment:  neutral
Materiality: 0.35
Item codes: 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AgeX draws $500K under secured convertible note with Juvenescence; due Feb 14, 2024
--------------------------------------------------------------------------------

- Drew $500,000 on Jan 3, 2024 from Amended and Restated Secured Convertible Promissory Note.
- Lender is Juvenescence Limited; repayment date set as February 14, 2024.
- Other terms incorporated by reference from Nov 14, 2023 Form 10-Q.
- Total outstanding under the note not disclosed in this filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000149315224001398/0001493152-24-001398-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000149315224001398/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-001398

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer